Library

eCommons

 

Convection Enhanced Drug Delivery for the Treatment of Brain Gliomas

Simple item page
dc.contributor.authorBrennan, James
dc.contributor.authorColangelo, Nicholas
dc.contributor.authorPendery, Leslie
dc.contributor.authorSkeans, Weston
dc.date.accessioned2009-05-08T13:49:21Z
dc.date.available2009-05-08T13:49:21Z
dc.date.issued2009-05-08T13:49:21Z
dc.description.abstractMalignant brain gliomas are almost always fatal, with a five year survival rate of only 3%. This is due in part to the difficulty of treating tumors chemically or surgically. They are often deep within the brain, where drugs cannot easily diffusive due to the blood-brain barrier and where surgery could be deadly. Emerging techniques for improved treatment include direct infusion of treatment drugs, like Paclitaxel, into the tumor in a procedure known as convection-enhanced drug delivery. These procedures require days of carefully monitored infusion to ensure tumor destruction while preserving surrounding tissue. To better understand the drug distribution and dosing options for different tumor sizes without dangerous medical tests, we have modeled the drug distribution within the tumor and surrounding tissue computationally. The model shows drug distributions consistent with current clinical results after a five day procedure. This model could now be used to better define dosing levels and procedure parameters to maximize tumor removal while preserving healthy tissue in individually unique cases.en_US
dc.identifier.urihttps://hdl.handle.net/1813/12644
dc.language.isoen_USen_US
dc.relation.ispartofseriesBEE 4530 Projectsen_US
dc.subjectDrug Deliveryen_US
dc.subjectBrian Gliomasen_US
dc.titleConvection Enhanced Drug Delivery for the Treatment of Brain Gliomasen_US
dc.typeterm paperen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2009BEE4530_Group1_FinalReport.pdf
Size:
536.65 KB
Format:
Adobe Portable Document Format
Download

Collections

BEE 4530 - 2009 Student Papers